Stepan Company
NYSE:SCLChemicals - Specialty
+$0.46 today
- Market cap
- $1.50B
- Beta
- 0.97
- P/E (TTM)
- -87.3
- EPS (TTM)
- -$0.62
- Dividend yield
- 2.89%
Volume 0.13M
Average 0.15M
SCL Net Income
Bottom-line profit, the starting point for calculating cash from operations.
Stepan CompanyNYSE: SCL
Net Income · Q1 FY2026 · quarter ended Mar 2026
Net income turns negative
Q1 FY2026 net income was -$41.41M, compared with $19.71M a year earlier. Trailing-twelve-month net income was -$14.22M. Over 3 fiscal years it compounded at -31.7% a year.
Context
- Net income amounted to 2.0% of revenue in FY2025, down 0.3 pp from a year earlier.
- Net income increased in 1 of the last 3 fiscal years.
What to watch
Whether net income reaches the consensus estimate from 2 analysts of $61.1M (+30.3%) for the fiscal year ending Dec 2026, a step up from the -6.9% reported in FY2025.
Sources:Cash Flow Analyst consensus estimates Text generated from reported figures; not investment advice.
- Latest quarterMar 2026
- -$41.41M-927.5% QoQ
- Last fiscal yearDec 2025
- $46.9M-6.9% YoY
- LTMMar 2026
- -$14.22M-125.3% YoY
| Horizon | Past | Forecast | Difference |
|---|---|---|---|
| Quarter | -310.1% | +23.6% | +333.7 pp |
| 1 year | -6.9% | +30.3% | +37.2 pp |
| 3-year CAGR | -31.7% | +25.6% | +57.3 pp |
| 5-year CAGR | — | — | |
| 10-year CAGR | — | — |
Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.
Net Income history
USD · from the cash flow
- Latest · FY2025
- 46.9M USD
- Year-over-year change
- -6.9%
- 4-year CAGR
- -23.6%
| Period | Period end | Net Income | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 46.9M | -6.9% |
| FY2024 | 2024-12-31 | 50.37M | +25.3% |
| FY2023 | 2023-12-31 | 40.2M | -72.7% |
| FY2022 | 2022-12-31 | 147.15M | +6.7% |
| FY2021 | 2021-12-31 | 137.9M | — |
Net Income vs competitors
How SCL compares with its peers on the latest reported figures
- Peers report in different currencies, so net income is compared through growth and share of revenue rather than absolute size.
- Its year-over-year change of -125.3% is the lowest of 11, against a peer median of +72.6%.
- Net income amounts to 0.6% of revenue for SCL, versus a peer median of 12.6%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | R$9.32B BRL | -26.5% | — | 14.0% | |
| LTM Mar 2026 | $173.88M USD | +412.4% | +218.5% | 645.7% | |
| LTM Mar 2026 | $121.49M USD | +61.1% | -29.9% | 18.9% | |
| LTM Mar 2026 | $111.27M USD | +84.2% | — | 8.1% | |
| LTM Apr 2026 | $102.85M USD | +42.9% | +35.8% | 15.7% | |
| LTM Mar 2026 | $77M USD | +254.8% | -4.0% | 4.1% | |
| LTM Mar 2026 | $74.08M USD | +350.5% | — | 31.4% | |
| LTM Mar 2026 | $61.76M USD | +438.4% | -55.2% | 7.5% | |
| LTM Apr 2026 | $54.97M USD | +11.1% | +112.7% | 11.2% | |
| LTM Mar 2026 | $16.38M USD | -84.2% | +5.5% | 0.8% | |
| LTM Mar 2026 | $14.22M USD | -125.3% | -31.7% | 0.6% | |
| Peer median (excluding SCL) | — | +72.6% | +5.5% | 12.6% | |
Competitors are the stored peer set for SCL. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | 137.9M | 147.15M | 40.2M | 50.37M | 46.9M |
| Depreciation & Amortization | 90.88M | 94.65M | 105.34M | 112.2M | 126.04M |
| Deferred Income Tax | (33.61M) | (27.45M) | 18.3M | (10.29M) | (1.4M) |
| Stock-Based Compensation | 11.72M | 13.85M | 5.74M | 5.35M | 2.16M |
| Change in Working Capital | (141.51M) | (68.96M) | (1.93M) | 2.79M | (22.04M) |
| Accounts Receivables | (104.23M) | (54.17M) | 32.01M | 9.04M | 23.72M |
| Inventory | (79.26M) | (99.39M) | 144.85M | (37.18M) | 500K |
| Accounts Payables | 44.41M | 54.17M | (158.92M) | 33.97M | (32.71M) |
| Other Working Capital | (2.44M) | 30.43M | (19.86M) | (3.04M) | (13.55M) |
| Other Non-Cash Items | 6.76M | 1.53M | 7.22M | 1.64M | (3.78M) |
| Operating Cash Flow | 72.14M | 160.76M | 174.88M | 162.05M | 147.88M |
| Capital Expenditures | (194.48M) | (301.55M) | (260.34M) | (122.78M) | (122.51M) |
| Acquisitions (Net) | (184.47M) | (9.69M) | 0 | 0 | 26.59M |
| Purchases of Investments | 0 | 0 | 0 | 0 | 0 |
| Sales of Investments | 0 | 0 | 0 | 0 | 0 |
| Other Investing Activities | 2.13M | 3.16M | 1.67M | 5.83M | 6.88M |
| Investing Cash Flow | (376.83M) | (308.09M) | (258.67M) | (116.95M) | (89.05M) |
| Debt Repayment | 165M | 223.69M | 66.86M | (28.69M) | 1.24M |
| Common Stock Issued | 0 | 0 | 2.8M | 1.11M | 104K |
| Common Stock Repurchased | (16.97M) | (24.95M) | 0 | 0 | 0 |
| Dividends Paid | (28.08M) | (30.57M) | (32.87M) | (33.95M) | (35.03M) |
| Other Financing Activities | (2.62M) | (1.96M) | (3.5M) | (3M) | (1.76M) |
| Financing Cash Flow | 117.33M | 166.21M | 33.28M | (64.52M) | (35.44M) |
| Effect of Forex Changes | (3.39M) | (4.32M) | 6.58M | (10.75M) | 9.63M |
| Net Change in Cash | (190.75M) | 14.56M | (43.93M) | (30.16M) | 33.02M |
| Free Cash Flow | (122.35M) | (140.79M) | (85.46M) | 39.28M | 25.37M |
Stepan Company
NYSE:SCL
Intrinsic Alpha fair value
Locked
Current Price
$66.05
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.